VistaGen Therapeutics, Inc. Soared
Mon, Aug 07, 2023 at 07:02 PM
VistaGen Therapeutics, Inc. (VTGN:NASDAQ) shot up at $13.05, representing a gain of 676.8%. On Mon, Aug 07, 2023, VTGN:NASDAQ touched a New 2-Week High of $13.05. The stock appeared on our News Catalysts scanner on Mon, Aug 07, 2023 at 03:06 PM in the 'BIOTECH' category. From Mon, Jul 24, 2023, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Mon, Aug 07, 2023 at $24.71 with a volume of 53M+.
About VistaGen Therapeutics, Inc. (VTGN:NASDAQ)
VistaGen Therapeutics Inc is a clinical-stage biopharmaceutical company that develops and commercializes product candidates for patients with central nervous system diseases. Its product AV-101 is currently being evaluated in a Phase 2 monotherapy study.
Top 10 Gainers:
- VistaGen Therapeutics, Inc. (VTGN:NASDAQ), 676.79%
- Save Foods Inc. (SVFD:NASDAQ), 143.75%
- Nektar Therapeutics (NKTR:NASDAQ), 91.51%
- ParaZero Technologies Ltd. (PRZO:NASDAQ), 40.27%
- Mallinckrodt plc (MNK:NYSEMKT), 32.12%
- Missfresh Limited (MF:NASDAQ), 31.82%
- Sequans Communications S.A. (SQNS:NYSE), 30.99%
- Tabula Rasa HealthCare, Inc. (TRHC:NASDAQ), 30.52%
- Peak Bio Inc Com (PKBO:NASDAQ), 28.48%
- Sovos Brands Inc. (SOVO:NASDAQ), 25.19%